Condensed Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Condensed Statements of Operations
Revenues	$ 19,190	$ 19,190	$ 57,571	$ 57,571
Operating expenses
Research and development	17,465	11,733	66,832	53,374
General and administrative	282,178	293,953	994,574	965,500
Total operating expenses	299,643	305,686	1,061,406	1,018,874
Loss from operations	(280,453)	(286,496)	(1,003,835)	(961,303)
Other income (expense)
Interest income	40	4,775	3,766	7,720
Interest expense	(52,186)	(52,186)	(155,424)	(101,223)
Total other expense	(52,146)	(47,411)	(151,658)	(93,503)
Loss before taxes	(332,599)	(333,907)	(1,155,493)	(1,054,806)
Provision for income taxes	0	0	0	0
Net loss	(332,599)	(333,907)	(1,155,493)	(1,054,806)
Deemed dividend related to warrants down round provision	0	0	0	(82,566)
Net loss attributable to common shareholders	$ (332,599)	$ (333,907)	$ (1,155,493)	$ (1,137,372)
Basic net loss per common share (in dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Diluted net loss per common share (in dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - basic (in shares)	133,441,788	131,506,494	133,328,778	130,790,212
Weighted average number of common shares outstanding - diluted (in shares)	133,441,788	131,506,494	133,328,778	130,790,212